This trial is active, not recruiting.

Condition diabetic ketoacidosis
Sponsor Marshall University
Start date December 2007
End date July 2008
Trial size 60 participants
Trial identifier NCT00589680, 9137


At this time, Saint Mary's Medical Center is currently in the process of implementing a standardized diabetic ketoacidosis (DKA) protocol. The first main goal of this project will be to evaluate patient outcomes to determine the effects of treating patients without a standardized protocol and to establish a baseline on how patients are being treating with DKA. The final goal of the project will be to compare outcomes of those patients not placed on the protocol to those that were treated using SMMC newly implemented DKA protocol. The overall goal of this project is to determine the benefit of an institutional DKA protocol.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Time perspective retrospective
Patients treated for DKA under DKA protocol implemented by hospital
To establish a baseline on how patients are being treating with DKA in general and without a standardized DKA protocol

Primary Outcomes

Hospital length of stay
time frame: Time in hospital

Secondary Outcomes

ICU length of stay
time frame: hospital stay
ICU length of stay Hypoglycemic events (BG<60)
time frame: hospital stay
Time to correction of glucose level and anion gap
time frame: hospital stay

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Admitted to St. Mary's Medical Center with DKA - >/= 18 years of age Exclusion Criteria: - < 18 years of age

Additional Information

Official title Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis
Principal investigator Sharon Jones, Pharm.D.
Trial information was received from ClinicalTrials.gov and was last updated in January 2008.
Information provided to ClinicalTrials.gov by Marshall University.